Aromics joins the BME Pre-Market Environment

by AROMICS

The company develops innovative compounds that that RNA of cancer-driven genes. Its lead compound, currently advancing into the clinical phase, targets the treatment of malignant mesothelioma, a disea...

Read more

AROMICS - one of the winners of Chemostart V Edition Program

by AROMICS

The Insud Pharma group has announced the winners of the V edition of its ChemoStart programme. The biotech companies Aromics and MiMark Diagnostics, based in the Barcelona Science Park, together with ...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New breakthrough in developing more pers...

by Universitat de Barcelona

The results show that adenocarcinoma exhibits much more active and fun...

Photos Stream